Polypharmacy With Common Diseases in Hospitalized Elderly Patients

van den Akker, 1998, Multimorbidity in general practice: prevalence, incidence, and determinants of co-occurring chronic and recurrent diseases, J Clin Epidemiol, 51, 367, 10.1016/S0895-4356(97)00306-5 Gijsen, 2001, Causes and consequences of comorbidity: a review, J Clin Epidemiol, 54, 661, 10.1016/S0895-4356(00)00363-2 Verbrugge, 1989, Comorbidity and its impact on disability, Milbank Q, 67, 450, 10.2307/3350223 Wolff, 2002, Prevalence, expenditures, and complications of multiple chronic conditions in the elderly, Arch Intern Med, 162, 2269, 10.1001/archinte.162.20.2269 Boyd, 2008, From bedside to bench: summary from the American Geriatrics Society/National Institute on Aging Research Conference on Comorbidity and Multiple Morbidity in Older Adults, Aging Clin Exp Res, 20, 181, 10.1007/BF03324775 Tinetti, 2004, Potential pitfalls of disease-specific guidelines for patients with multiple conditions, N Engl J Med, 351, 2870, 10.1056/NEJMsb042458 Boyd, 2005, Clinical practice guidelines and quality of care for older patients with multiple comorbid diseases: implications for pay for performance, JAMA, 294, 716, 10.1001/jama.294.6.716 Gurwitz, 2004, Polypharmacy: a new paradigm for quality drug therapy in the elderly?, Arch Intern Med, 164, 1957, 10.1001/archinte.164.18.1957 Hajjar, 2007, Polypharmacy in elderly patients, Am J Geriatr Pharmacother, 5, 345, 10.1016/j.amjopharm.2007.12.002 Lund, 2010, Inappropriate prescribing predicts adverse drug events in older adults, Ann Pharmacother, 44, 957, 10.1345/aph.1M657 Spinewine, 2007, Appropriate prescribing in elderly people: how well can it be measured and optimised?, Lancet, 370, 173, 10.1016/S0140-6736(07)61091-5 Veehof, 2000, The development of polypharmacy: a longitudinal study, Fam Pract, 17, 261, 10.1093/fampra/17.3.261 Charlson, 1987, A new method of classifying prognostic comorbidity in longitudinal studies: development and validation, J Chronic Dis, 40, 373, 10.1016/0021-9681(87)90171-8 Ferner, 2006, Communicating information about drug safety, BMJ, 333, 143, 10.1136/bmj.333.7559.143 Wawruch, 2008, Polypharmacy in elderly hospitalised patients in Slovakia, Pharm World Sci, 30, 235, 10.1007/s11096-007-9166-3 Corsonello, 2007, Polypharmacy in elderly patients at discharge from the acute care hospital, Ther Clin Risk Manage, 3, 197, 10.2147/tcrm.2007.3.1.197 Schuler, 2008, Polypharmacy and inappropriate prescribing in elderly internal-medicine patients in Austria, Wien Klin Wochenschr, 120, 733, 10.1007/s00508-008-1089-z Procyshyn, 2010, Persistent antipsychotic polypharmacy and excessive dosing in the community psychiatric treatment setting: a review of medication profiles in 435 Canadian outpatients, J Clin Psychiatry, 71, 566, 10.4088/JCP.08m04912gre Antonelli Incalzi, 2005, Depression and drug utilization in an elderly population, Ther Clin Risk Manage, 1, 55, 10.2147/tcrm.1.1.55.53603 Nobili, 2011, Polypharmacy, length of hospital stay, and in-hospital mortality among elderly patients in internal medicine wards: the REPOSI study, Eur J Clin Pharmacol, 67, 507, 10.1007/s00228-010-0977-0